Cargando…

Effects of quarantine applied during the COVID-19 pandemic on mental health and quality of life in patients with multiple sclerosis and healthy controls

BACKGROUND: The coronavirus outbreak, which emerged in Wuhan, China, in late 2019 and spread to the world, has changed each of our lives. OBJECTIVE: To investigate the effects of quarantine on depression, anxiety, sleep quality, fatigue, and SF-36 of multiple sclerosis (MS) patients during the COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koc, Emine Rabia, Demir, Aylin Bican, Topaloglu, Ezgi, Turan, Omer Faruk, Ozkaya, Guvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777171/ https://www.ncbi.nlm.nih.gov/pubmed/35061136 http://dx.doi.org/10.1007/s10072-022-05901-7

Ejemplares similares

MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine
por: Seferoğlu, Meral, et al.
Publicado: (2021)

The Impact of the COVID-19 Quarantine on Sexual Life in Italy
por: Cito, Gianmartin, et al.
Publicado: (2021)

Efficacy of Accelerated Vaccination against Hbv to Achieve Antibody formation in Multiple Sclerosis Patients Receiving Anti-Cd20 Therapy
por: Koc, Emine Rabia, et al.
Publicado: (2023)

Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy
por: Parodi, Italo Carlo, et al.
Publicado: (2020)

Migrants’ Quarantine and COVID-19 Pandemic in Italy: a Medico-anthropological View
por: Di Meo, Silvia, et al.
Publicado: (2021)

Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy
por: Faruk, Turan Ömer, et al.
Publicado: (2022)

Subjective cognitive failures and their psychological correlates in a large Italian sample during quarantine/self-isolation for COVID-19
por: Santangelo, Gabriella, et al.
Publicado: (2021)

Infection control behaviours, intra‐household transmission and quarantine duration: a retrospective cohort analysis of COVID‐19 cases
por: McCarthy, Kate L., et al.
Publicado: (2022)

Lessons from COVID-19-free Vanuatu: intensive health operations for Phase 1 of repatriation and quarantine, May–July 2020
por: Tapo, Posikai Samuel, et al.
Publicado: (2021)

The Impact of Quarantines, Lockdowns, and ‘Reopenings’ on the Commercialization of Science: Micro and Macro Issues
por: Siegel, Donald S., et al.
Publicado: (2021)

Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19
por: Cimolai, Nevio
Publicado: (2020)

An online course on applied biochemistry and molecular biology through case‐based learning
por: Plasencia, Javier
Publicado: (2022)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
por: Sadeghmousavi, Shaghayegh, et al.
Publicado: (2020)

Impact of COVID-19 lockdown on progressive multiple sclerosis patients
por: Vercellino, Marco, et al.
Publicado: (2022)

Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
por: Devogelaere, Jens, et al.
Publicado: (2020)

Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19
por: De Marchi, Fabiola, et al.
Publicado: (2020)

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
por: Bonavita, Simona, et al.
Publicado: (2020)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

Against COVID‐19 vaccination of healthy children
por: Kraaijeveld, Steven R., et al.
Publicado: (2022)

Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail
por: Bombaci, Alessandro, et al.
Publicado: (2020)

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
por: Habek, Mario
Publicado: (2021)

Beyond SARS-CoV-2: Lessons That African Governments Can Apply in Preparation for Possible Future Epidemics
por: Oboh, Mary Aigbiremo, et al.
Publicado: (2020)

Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era
por: Toscano, Simona, et al.
Publicado: (2022)

Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
por: Sparaco, Maddalena, et al.
Publicado: (2022)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
por: Kuzu Kumcu, Müge, et al.
Publicado: (2022)

Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study
por: Dalla Costa, Gloria, et al.
Publicado: (2020)

The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness
por: De Lucia, Natascia, et al.
Publicado: (2020)

Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
por: Alirezaei, Mohammad, et al.
Publicado: (2021)

Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report
por: Giordano, Antonino, et al.
Publicado: (2021)

COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis
por: Yazdani, Amid, et al.
Publicado: (2022)

Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
por: Yetkin, Mehmet Fatih, et al.
Publicado: (2021)

Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge
por: D’Apolito, Maria, et al.
Publicado: (2023)

Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study
por: Affinito, Giuseppina, et al.
Publicado: (2023)

Junior doctors’ mental health and coronavirus disease safety concerns
por: Bartholomew, Alexandra, et al.
Publicado: (2022)

Acute cerebellitis requiring posterior fossa decompression after COVID-19 vaccination in an ocrelizumab-treated patient with multiple sclerosis
por: Brecl Jakob, Gregor, et al.
Publicado: (2022)

Current and Future Challenges in the Delivery of Mental Healthcare during COVID-19
por: Gautam, Mohan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a2jfs7mgf281rve3al34vvg1ib